35 results
8-K/A
EX-10.1
CHRS
Coherus Biosciences Inc
21 May 24
Financial Statements and Exhibits
5:14pm
limiting the generality of the foregoing, Borrower and each of its Subsidiaries has conducted commercially reasonable data security audits and penetration
8-K
EX-2.1
wu3rsnbg
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
424B3
l5bre9
26 Jul 23
Prospectus supplement
4:59pm
S-4/A
3ad8bi dnk
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
S-4
55nz9x5pb8dgx0kbbr77
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
425
nqihxgqci 4g75s6m
16 Jun 23
Business combination disclosure
8:08am
425
t6g3kj 5gxm1j
16 Jun 23
Business combination disclosure
7:09am
8-K
EX-2.1
yzgaoock6m
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am
8-K
EX-1.1
1d49n3ez
18 May 23
Other Events
5:02pm